Cite
HARVARD Citation
Quartier, P. et al. (n.d.). AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study. Annals of the rheumatic diseases. p. 705. [Online].